Point72 Hong Kong’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,656
| Closed | -$92K | – | 1971 |
|
|
2022
Q2 | $92K | Buy |
+6,656
| New | +$92K | ﹤0.01% | 776 |
|
|
2021
Q4 | – | Sell |
-178
| Closed | -$5K | – | 1890 |
|
|
2021
Q3 | $5K | Sell |
178
-6,064
| -97% | -$170K | ﹤0.01% | 1242 |
|
|
2021
Q2 | $185K | Buy |
6,242
+5,655
| +963% | +$168K | 0.01% | 620 |
|
|
2021
Q1 | $16K | Buy |
+587
| New | +$16K | ﹤0.01% | 1010 |
|
|
2020
Q4 | – | Sell |
-713
| Closed | -$18K | – | 1676 |
|
|
2020
Q3 | $18K | Buy |
+713
| New | +$18K | ﹤0.01% | 892 |
|
|
2020
Q2 | – | Sell |
-234
| Closed | -$3K | – | 1476 |
|
|
2020
Q1 | $3K | Sell |
234
-1,717
| -88% | -$22K | ﹤0.01% | 838 |
|
|
2019
Q4 | $32K | Buy |
+1,951
| New | +$32K | 0.01% | 781 |
|
|
2019
Q3 | – | Sell |
-179
| Closed | -$2K | – | 1404 |
|
|
2019
Q2 | $2K | Buy |
+179
| New | +$2K | ﹤0.01% | 1015 |
|
|
2018
Q2 | – | Sell |
-540
| Closed | -$17K | – | 1236 |
|
|
2018
Q1 | $17K | Buy |
+540
| New | +$17K | 0.01% | 641 |
|